TCR-Solutions is pleased to be sponsoring the next Creative Disruption Forum: Future of NextGen Therapies, Clinical Trials & Funding, taking place on Thursday 19 March 2026, from 10:00 am to 4:00 pm at ARC West London.
As a UK-based CRO, TCR-Solutions works with biotech, pharmaceutical, academic and medical device sponsors to design, plan and deliver clinical trials with a strong hospital-focused approach. The company’s site-centric model makes this forum a natural fit, particularly as the industry continues to explore how innovation in advanced therapies can be translated into successful and efficient clinical development.
The event will feature thought-provoking conversations on where next-generation therapies are heading in 2026, how AI is reshaping clinical trial design, and how companies can prepare effectively for future funding rounds. Confirmed speakers include Peter MacLennan, CEO of TCR-Solutions, alongside senior leaders from across the biotech, clinical research, investment and life sciences sectors.
At TCR-Solutions, we believe strong collaboration across sponsors, hospitals, researchers and industry partners is essential to delivering better clinical studies and better outcomes for patients. Supporting events such as the Creative Disruption Forum reflects our commitment to helping shape productive conversations around the future of clinical research and the evolving needs of innovative biotech and life sciences companies.
We look forward to joining fellow innovators, researchers and industry leaders for what promises to be an engaging and insightful day.
Event details
Creative Disruption Forum: Future of NextGen Therapies,
Clinical Trials &Funding Date: Thursday, 19 March 2026
Time: 10:00 AM – 4:00 PM
Venue: ARC West London